253 related articles for article (PubMed ID: 35720420)
1. Upregulation of Atypical Cadherin FAT1 Promotes an Immunosuppressive Tumor Microenvironment
Irshad K; Srivastava C; Malik N; Arora M; Gupta Y; Goswami S; Sarkar C; Suri V; Mahajan S; Gupta DK; Suri A; Chattopadhyay P; Sinha S; Chosdol K
Front Immunol; 2022; 13():813888. PubMed ID: 35720420
[TBL] [Abstract][Full Text] [Related]
2. Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221-3p/222-3p axis in glioblastoma.
Malik N; Kundu A; Gupta Y; Irshad K; Arora M; Goswami S; Mahajan S; Sarkar C; Suri V; Suri A; Chattopadhyay P; Sinha S; Chosdol K
Mol Carcinog; 2023 Dec; 62(12):1817-1831. PubMed ID: 37606187
[TBL] [Abstract][Full Text] [Related]
3. NFкB is a critical transcriptional regulator of atypical cadherin FAT1 in glioma.
Srivastava C; Irshad K; Gupta Y; Sarkar C; Suri A; Chattopadhyay P; Sinha S; Chosdol K
BMC Cancer; 2020 Jan; 20(1):62. PubMed ID: 31992226
[TBL] [Abstract][Full Text] [Related]
4. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.
Dikshit B; Irshad K; Madan E; Aggarwal N; Sarkar C; Chandra PS; Gupta DK; Chattopadhyay P; Sinha S; Chosdol K
Oncogene; 2013 Aug; 32(33):3798-808. PubMed ID: 22986533
[TBL] [Abstract][Full Text] [Related]
5. STAT1 mediated downregulation of the tumor suppressor gene PDCD4, is driven by the atypical cadherin FAT1, in glioblastoma.
Khan MT; Almas M; Malik N; Jalota A; Sharma S; Ali SA; Luthra K; Suri V; Suri A; Basak S; Seth P; Chosdol K; Sinha S
Cell Signal; 2024 Jul; 119():111178. PubMed ID: 38640981
[TBL] [Abstract][Full Text] [Related]
6. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
[TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor-β1 (TGF-β1) and E-cadherin in glioma.
Yang L; Liu M; Deng C; Gu Z; Gao Y
Tumour Biol; 2012 Oct; 33(5):1477-84. PubMed ID: 22544614
[TBL] [Abstract][Full Text] [Related]
8. FAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma.
Madan E; Dikshit B; Gowda SH; Srivastava C; Sarkar C; Chattopadhyay P; Sinha S; Chosdol K
Int J Cancer; 2016 Dec; 139(11):2570-82. PubMed ID: 27536856
[TBL] [Abstract][Full Text] [Related]
9. Glioma-derived exosome Lncrna Agap2-As1 promotes glioma proliferation and metastasis by mediating Tgf-β1 secretion of myeloid-derived suppressor cells.
Tian Y; Gao X; Yang X; Chen S; Ren Y
Heliyon; 2024 May; 10(9):e29949. PubMed ID: 38699039
[TBL] [Abstract][Full Text] [Related]
10. Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment.
Kowalska W; Bojarska-Junak A
Folia Histochem Cytobiol; 2020; 58(1):25-36. PubMed ID: 32227331
[TBL] [Abstract][Full Text] [Related]
11. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
12. [The effect of HOXC10 gene on biological behaviors of glioma cells and mechanism in tumor microenvironment].
Jiang WY; Lei QY; Liu SS; Yang L; Yang B; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):228-237. PubMed ID: 35316872
[No Abstract] [Full Text] [Related]
13.
Chen C; Li Y; Liu H; Liao M; Yang J; Liu J
Heliyon; 2024 Apr; 10(7):e28356. PubMed ID: 38560204
[TBL] [Abstract][Full Text] [Related]
14. IGFBP3 induces PD-L1 expression to promote glioblastoma immune evasion.
Zhao L; Wang Y; Mu P; Zhang X; Qi R; Zhang Y; Zhang H; Zhu X; Dong Z; Dong Y
Cancer Cell Int; 2024 Feb; 24(1):60. PubMed ID: 38326861
[TBL] [Abstract][Full Text] [Related]
15. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
[TBL] [Abstract][Full Text] [Related]
16. Investigation of immunosuppressive mechanisms in a mouse glioma model.
Ksendzovsky A; Feinstein D; Zengou R; Sharp A; Polak P; Lichtor T; Glick RP
J Neurooncol; 2009 May; 93(1):107-14. PubMed ID: 19430886
[TBL] [Abstract][Full Text] [Related]
17. MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.
Wang QW; Sun LH; Zhang Y; Wang Z; Zhao Z; Wang ZL; Wang KY; Li GZ; Xu JB; Ren CY; Ma WP; Wang HJ; Li SW; Zhu YJ; Jiang T; Bao ZS
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34667077
[TBL] [Abstract][Full Text] [Related]
18. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.
Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V
Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 and myeloid-derived suppressor cells: A cancerous partnership.
Mojsilovic S; Mojsilovic SS; Bjelica S; Santibanez JF
Dev Dyn; 2022 Jan; 251(1):105-124. PubMed ID: 33797140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
